Hyperpolarized 13C-MRI and Radiomics in Rectal Cancer
Recruiting
Observational Study
Neoadjuvant Chemoradiotherapy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is testing new imaging and analysis methods to improve how doctors predict treatment response in rectal cancer patients receiving chemoradiotherapy. Current MRI scans sometimes miss complete tumor response, which can lead to unnecessary surgery. To address this, researchers will use a special MRI technique called hyperpolarized carbon-13 MRI, along with blood and tissue analysis (metabo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients with biopsy proved rectal adenocarcinoma.
2. Patents will undergo neoadjuvant chemoradiation therapy (nCRT).
3. Patients more than 20-year-old.
Exclusion Criteria:
2\. Contraindication to MRI study (e.g., claustrophobia or non-removable devices or implants that are…
Contacts